Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Jean Henrik Braconier"'
Autor:
Jean Henrik Braconier, Claes Söderström, Anders G. Sjöholm, Karen Kvist Christensen, Poul Christensen
Publikováno v:
Acta Pathologica Microbiologica Scandinavica Series C: Immunology. :251-256
Phagocytic killing of group B streptococci serotypes Ia, Ib, IIR- (R protein negative), IIR+ (R protein positive), IIIR- and IIIR+ by human granulocytes was studied after opsonization in properdin deficient serum, pooled normal human serum and in sel
Autor:
Stephanos J. Hadziyannis, H. L. Tillmann, J.I. Esteban, Robert D. Goldin, R. Winkler, Jean Henrik Braconier, Alfredo Alberti, Christian Trepo, Pierre Pradat, Silvia Sauleda, Giorgio Maria Saracco, Howard C. Thomas, M. P. Manns, M. Rizzetto, Mark Thursz
Publikováno v:
Journal of Viral Hepatitis. 14:556-563
The aims of the study were to verify the longterm effect of time on viral clearance in hepatitis C virus (HCV) patients and to find out factors possibly associated with disease progression. A total of 1641 patients recruited from eight European centr
Autor:
Jean Henrik Braconier, Lennart Truedsson, Gunnar Sturfelt, Anders G. Sjöholm, Göran Jönsson, Anders A. Bengtsson
Publikováno v:
Rheumatology. 46:1133-1139
Objective. To analyse rheurnatological manifestations, organ damage and autoimmune responses in a large cohort of patients (n = 45) with homozygous C2 deficiency (C2D) and long-term follow-up. Methods. Medical records were reviewed and were supplemen
Autor:
Hartmut J. Ehrlich, J Wallvik, Simone Walter, Karl Birthistle, Heinz Leibl, Jukka Nikoskelainen, Werner Engl, Jean Henrik Braconier, Borislava G. Pavlova, Peter Lanbeck, JT Lumio, J Bjorkander
Publikováno v:
Vox Sanguinis. 90:286-293
Background and Objectives The aim of this study was to evaluate the pharmacokinetics, efficacy and safety of a newly developed 10% liquid immunoglobulin preparation in patients with primary immunodeficiency diseases. This new preparation for intraven
Autor:
Robert D. Goldin, Maria Chiaramonte, S. Marshall, Mark Thursz, Leland J. Yee, Jean Henrik Braconier, Andrew J. Hall, Howard C. Thomas, Alfredo Alberti, Peter Kelleher
Publikováno v:
Journal of Viral Hepatitis. 11:459-464
We examined correlates of antinuclear antibody (ANA) positivity (ANA+) in individuals with chronic hepatitis C virus (HCV) infection and the effect of positivity on clinical outcome of HCV. Pretreatment sera from 645 patients from three centres in Sw
Publikováno v:
Clinical Infectious Diseases. 32:1523-1531
Escherichia coli strains from patients with febrile urinary tract infections (n=73) were examined for pap genotype and P fimbrial expression in relation to bacteremia and patients' background variables. Most isolates were pap(+) by DNA hybridization
Autor:
Sandrine Touzet, J.I. Esteban, Stephanos J. Hadziyannis, Michael P. Manns, Cyrille Colin, Jean-henrik Braconier, Pierre Pradat, Laure Kraemer, Mark Thursz, Hans L. Tillmann, Christian Trepo, Howard Thomas, Alfredo Alberti, Giogio Saracco, Denise Lanoir, Silvia Sauleda, François Bailly, Rosa Cristina Coppola
Publikováno v:
Scopus-Elsevier
Hepatitis C is now recognized as the most common infection causing chronic liver disease in the European population. Our aim was to assess the prevalence of the antibody to hepatitis C virus (HCV), and the incidence of HCV seroconversion in the gener
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 19:21-26
The objective of this study was to investigate the epidemiology, etiology, and long-term outcome of an extended outbreak of acute hepatitis that occurred in an area of Sweden between 1969 and 1972. The outbreak was analyzed retrospectively by retesti
Autor:
Gunnar Norkrans, Jean Henrik Braconier, Ola Weiland, Olle Reichard, Ingrid Uhnoo, Aril Frydén
Publikováno v:
Karolinska Institutet
A total of 172 Swedish patients treated with interferon-alpha for at least 24 weeks and followed-upor =24 weeks after treatment was stopped were analysed for pre-treatment factors of importance for achieving a virological sustained response (SR). Fur
Autor:
Aril Frydén, Olle Reichard, Jean-Henrik Braconier, Ola Weiland, Gunnar Norkrans, Anders Sönnerborg
Publikováno v:
The Lancet. 351:83-87
Summary Background Pilot studies suggested that more patients with chronic hepatitis C virus (HCV) infection had a sustained virological response when treated with the combination of interferon α-2b and ribavirin than with interferon α-2b alone. We